Glenmark Pharmaceuticals Ltd
Intimation of Record Date for Dividend
DIVIDEND
▲ Positive Development
LOW RISK
📅 Filed on BSE: 31 Jul 2026, 06:52 PM IST · BSE ID: e4ec1125-03e7-4312-8127-0dffa08f9dc0
View Original BSE Filing (PDF)
💡
In Simple Terms
Glenmark Pharmaceuticals set a date for shareholders to be eligible for a dividend and reviewed their latest financial results.
🤖 AI Summary
- Glenmark Pharmaceuticals board approved Q1 FY27 financial results on July 31, 2026.
- Record date for dividend entitlement set as Monday, August 31, 2026.
- The 48th Annual General Meeting scheduled for September 11, 2026.
- Financial results for the quarter ended June 30, 2026, were reviewed.
🔢 Key Numbers — exact figures from BSE filing, not rounded
AGM Date
September 11, 2026
Record Date
August 31, 2026
Financial Year for Dividend
Ended March 31, 2026
👥 What This Means For Shareholders
✅
Action Required
No action is required by shareholders at this time. Shareholders registered by August 31, 2026, will be entitled to the dividend.
👤
Who Is Affected
All shareholders of Glenmark Pharmaceuticals Limited are affected by the setting of the record date for dividend entitlement for the Financial Year ended March 31, 2026.
🔍
Management Signal
Management is proceeding with the distribution of dividends and standard corporate governance procedures as per schedule.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 results announcement
Outcome of the 48th AGM on September 11, 2026
Dividend payment date after AGM
LOW RISK
This filing pertains to routine financial results disclosure and dividend record date.
💡 Investor Takeaway
Glenmark Pharmaceuticals announced its Q1 FY27 results and set August 31, 2026, as the record date for dividend entitlement for the FY26 dividend. The AGM will be held on September 11, 2026.
❓ Frequently Asked Questions
What is Glenmark Pharmaceuticals' record date for dividend?
Glenmark Pharmaceuticals has set Monday, August 31, 2026, as the record date for determining entitlement to the dividend for the Financial Year ended March 31, 2026.
When is Glenmark Pharmaceuticals' Annual General Meeting?
The 48th Annual General Meeting of Glenmark Pharmaceuticals Limited will be held on Friday, September 11, 2026, at 2:00 P.M.
What financial results did Glenmark Pharmaceuticals' board approve?
The Board of Glenmark Pharmaceuticals approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
Questions based on this BSE filing only. For information purposes.